![]()
|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Papers In Press, published online ahead of print April 22, 2003
Department of Biological Chemistry, The Weizmann Institute of Science, Rehovot 76100
Corresponding Author: tony.futerman{at}weizmann.ac.il
We recently demonstrated that elevation of intracellular glucosylceramide (GlcCer) levels results in increased functional Ca2+ stores in cultured neurons, and suggested that this may be due to modulation of ryanodine receptors (RyaRs) by GlcCer (Korkotian, E., Schwarz, A., Pelled, D., Schwarzmann, G., Segal, M. and Futerman, A.H. J. Biol. Chem. 274, 21673-21678). We now systematically examine the effects of exogenously added GlcCer, other glycosphingolipids (GSLs) and their lyso-derivatives on Ca2+-release from rat brain microsomes. GlcCer had no direct effect on Ca2+-release, but rather augmented agonist-stimulated Ca2+-release via RyaRs, through a mechanism that may involve the redox sensor of the RyaR, but had no effect on Ca2+-release via inositol 1,4,5-trisphosphate receptors. Other GSLs and sphingolipids, including galactosylceramide, lactosylceramide, ceramide, sphingomyelin, sphingosine-1-phosphate, sphinganine-1-phosphate and sphingosylphosphorylcholine had no effect on Ca2+-mobilization from rat brain microsomes, but both galactosylsphingosine (psychosine) and glucosylsphingosine stimulated Ca2+-release, although only galactosylsphingosine mediated Ca2+-release via the RyaR. Finally, we demonstrated that GlcCer levels were ~10-fold higher in microsomes prepared from the temporal lobe of a type 2 Gaucher disease patient compared to a control, and Ca2+-release via the RyaR was significantly elevated, which may be of relevance for explaining the pathophysiology of neuronopathic forms of Gaucher disease.
J. Biol. Chem, 10.1074/jbc.M300212200
Submitted on January 8, 2003
Revised on April 14, 2003
Accepted on April 22, 2003
Glucosylceramide and glucosylsphingosine modulate calcium mobilizationfrom brain microsomes via different mechanisms
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
C. M. Walden, R. Sandhoff, C.-C. Chuang, Y. Yildiz, T. D. Butters, R. A. Dwek, F. M. Platt, and A. C. van der Spoel Accumulation of Glucosylceramide in Murine Testis, Caused by Inhibition of beta-Glucosidase 2: IMPLICATIONS FOR SPERMATOGENESIS J. Biol. Chem., November 9, 2007; 282(45): 32655 - 32664. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Aharon-Peretz, H. Rosenbaum, and R. Gershoni-Baruch Mutations in the Glucocerebrosidase Gene and Parkinson's Disease in Ashkenazi Jews N. Engl. J. Med., November 4, 2004; 351(19): 1972 - 1977. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Pelled, E. Lloyd-Evans, C. Riebeling, M. Jeyakumar, F. M. Platt, and A. H. Futerman Inhibition of Calcium Uptake via the Sarco/Endoplasmic Reticulum Ca2+-ATPase in a Mouse Model of Sandhoff Disease and Prevention by Treatment with N-Butyldeoxynojirimycin J. Biol. Chem., August 8, 2003; 278(32): 29496 - 29501. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |